The month of March can turn out to be pretty challenging as far as biotech stocks go. Situation can…
Zarxio, the bio similar drug manufactured by Novartis AG (ADR) (NYSE:NVS) got approved by the US Food and Drug Administration,…
Incepta Pharmaceuticals Ltd. has come forward with a generic version of the drug Sovaldi, of the Gilead Sciences Inc. (NASDAQ:GILD).This…
Actavis Plc (NYSE:ACT) has the honor of culminating the second-largest corporate bond and made a record making sale on Tuesday. …
Yesterday’s extended market hours held a great surprise in them. The Q4 financial results had been announced after the closure…
In order to expand its present earning condition by its products and aiming to add up several Cardiovascular tools, Cardinal…